2008 financial summary

2008 financial summary (audited)

Revenues (in thousands)

Foundations

$113,211

US Government

40,321

Other governments, nongovernmental

 

organizations (NGOs), multilaterals

21,547

Individuals/other

11,135

Investments

1,161

Total revenue

$187,375

Expenses (in thousands)

Program services

Programs:

 

Emerging and epidemic diseases

$22,351

Health technologies

10,095

Maternal and child health and nutrition

7,928

Reproductive health

16,081

Vaccines and immunization

27,305

Cross-program

125

Subtotal programs

83,885

Program subawards

79,771

Subtotal program services

163,656

Support services

Management and general

21,744

Bid and proposal

2,474

Fundraising

1,311

Subtotal support services

25,529

Total expenses

$189,185

Assets and liabilities

Assets (in thousands)

Grants receivable

$453,235

Invested grant funds

251,542

Cash and cash equivalents

72,367

Other

9,010

Total assets

$786,154

Net assets and liabilities (in thousands)

Net assets

 

Grant funds temporarily restricted

$753,225

Unrestricted assets

13,382

Permanently restricted assets

3,363

Total net assets

769,970

Current liabilities

16,184

Total net assets and liabilities

$786,154

Figures are presented in US dollars.

Notes: The above financial summary is an excerpt from PATH’s audited financial statements, which are audited by the firm Clark Nuber. Full copies are available on our website at www.path.org.

PATH is an international, nonprofit, nongovernmental organization. Our mission is to improve the health of people around the world by advancing technologies, strengthening systems, and encouraging healthy behaviors. Contributions to PATH are tax-exempt under US IRS code 501(c)(3).

 Back | Next 

Sources of revenue

Pie chart showing sources of revenue: foundations and corporations, 60.5%; US Government, 21.5%; other governments/NGOs/multilaterals, 11.5%; individuals/other, 5.9%; investments, 0.6%

Expense allocation

Pie chart showing expense allocation: program services, 86.5%; management and general, 11.3%; bid and proposal, 1.3%; fundraising, 0.9%

Use of funds

Pie chart showing use of funds: vaccines and immunization, 32.7%; emerging and epidemic diseases, 26.6%; reproductive health, 19.2%; health technologies, 12.0%; maternal and child health, 9.5%